Microbot Medical signs Lovell Government Services deal to sell LIBERTY system to US federal health facilities

Microbot Medical Inc

Microbot Medical Inc

MBOT

0.00
  • Microbot Medical signed an agreement with Lovell Government Services to expand sales access for its LIBERTY endovascular robotic system.
  • Deal targets more than 2,000 US government healthcare facilities, including Veterans Affairs and Defense Department sites.
  • LIBERTY is slated to be added to Lovell’s Federal Supply Schedule, with activation expected in Q3 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.